- ￥1000 - 1800
- Solarbio|ActivAb
- 北京
- K012382RR
- 2025年09月16日
- IHC;IF;IP;FCM;WB
- Rabbit
- Rat;Mouse;Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
A synthetic peptide of human Src substrate cortactin
- 亚型：
IgG
- 保存条件：
Store at -20℃. Avoid freeze / thaw cycles.
- 克隆性：
Recombinant Antibody
- 标记物：
Biotin，Cy3，Cy3.5，Cy5，Cy5.5，Cy7，FITC，HRP，RBITC，Solar Fluor 350，Solar Fluor 405，Solar Fluor 488，Solar Fluor 532，Solar Fluor 555，Solar Fluor 568，Solar Fluor 594，Solar Fluor 633，Solar Fluor 640，Solar Fluor 647，Solar Fluor 660，Solar Fluor 680，Solar Fluor 750
- 适应物种：
Rat;Mouse;Human
- 抗原来源：
A synthetic peptide of human Src substrate cortactin
- 目录编号：
2017
- 级别：
实验级别
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- 宿主：
Rabbit
- 应用范围：
IHC;IF;IP;FCM;WB
- 浓度：
WB 1:1000-5000. IHC 1:100-200. IF 1:50-200. IP 1:20-50. FCM 1:20-100.
- 靶点：
Src substrate cortactin
- 抗体英文名：
Anti-Src substrate cortactin Recombinant Antibody
- 抗体名：
皮层肌动蛋白重组抗体
- 规格：
100ul/50ul
| 规格： | 100ul | 产品价格： | ￥1800.0 |
|---|---|---|---|
| 规格： | 50ul | 产品价格： | ￥1000.0 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Proteolysis of Cortactin by Calpain in Platelets and In Vitro
by selective hydrolysis of platelet proteins in a manner dependent on platelet activation (1 ). One of the substrates of calpain was found to be cortactin (2 ), a filamentous actin (F-actin) crosslinker (3 ), and a prominent substrate of Src
Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
A growing number of recombinant antibodies is being developed for immunotherapy of cancer (1 ,2 ) (see also Chapter 2 ). Although these recombinant antibodies can exhibit a potent anti-tumoral activity in vitro, efficacy in vivo
Rapid Purification of Recombinant Antibody Fragments for Catalysis Screening
. Direct screening for catalysis may permit isolation of more efficient antibody catalysts, since this approach obviates the requirement for strong binding to substrate ground states (or presumed transition state analogs). To this end, we have developed
技术资料暂无技术资料 索取技术资料
